MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Laboratory Corporation of America Holdings EBITDA per Share 2011-2026 | LH
Annual EBITDA per Share Laboratory Corporation of America Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.8 | 20.6 | 15 | 22.4 | 38.9 | 31.6 | 16.6 | 15.8 | 16.1 | 15.1 | 13 | 11.9 | 12.8 | 12.1 | 11.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.9 | 11.4 | 18.5 |
Quarterly EBITDA per Share Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.61 | 5.55 | 5.89 | - | 3.78 | 4.24 | 5.66 | - | 3.56 | 3.58 | 5.34 | - | 4.69 | 5.19 | 9.11 | - | 13.8 | 8.18 | 12.7 | - | 15.3 | 6.02 | -0.49 | 3.46 | 7.8 | 6.25 | 4.6 | 3.11 | 7.46 | 6.38 | 4.4 | 3.24 | 7 | 5.71 | 4.35 | - | 6.73 | 6 | 4.15 | - | 6.41 | 5.39 | 2.56 | - | 4.99 | 4.37 | 13.6 | - | 4.65 | 4.15 | 3.42 | - | 4.66 | 4.23 | 3.7 | - | 4.11 | 3.4 | 2.93 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 | -0.49 | 5.64 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
-0.07 | $ 19.24 | -22.26 % | $ 558 M |  USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.58 | -2.53 % | $ 175 M |  China |
 |
Agilent Technologies
A
|
5.49 | $ 118.65 | 0.82 % | $ 36.1 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 21.44 | 2.39 % | $ 1.14 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 428.71 | 0.45 % | $ 12.4 B | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.93 | 17.68 % | $ 2.57 M | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.09 | -0.49 % | $ 379 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.07 | 2.02 % | $ 1.16 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 18.73 | 4.87 % | $ 419 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 219.82 | 2.2 % | $ 21.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 27.16 | -0.26 % | $ 25.8 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 181.68 | -0.03 % | $ 9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Personalis
PSNL
|
-0.97 | $ 5.99 | -1.32 % | $ 355 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 15.11 | 1.27 % | $ 457 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 92.26 | 0.01 % | $ 11.6 B | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.95 | 0.02 % | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 125.0 | 0.7 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
-3.01 | $ 138.71 | -2.71 % | $ 22.1 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 5.36 | - | $ 224 M | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.0 | -5.22 % | $ 8.85 M | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.59 | -1.99 % | $ 212 M | Irlanda |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 58.54 | -1.66 % | $ 3.5 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.19 | -0.68 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 474.46 | 0.32 % | $ 179 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 91.0 | 5.63 % | $ 6.14 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 130.71 | -6.26 % | $ 6.11 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.25 | 0.76 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 190.84 | 0.9 % | $ 21.2 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 350.49 | 0.27 % | $ 20.9 B | USA |